Cancer Innovation
The Master of Research in Cancer Innovation at Imperial College London is a one-year, full-time program focused on developing new technologies and approaches to cancer treatment and diagnosis. Students will explore innovative research in cancer biology, including the development of targeted therapies, immunotherapy, and novel cancer diagnostics. The program combines laboratory research with clinical applications, allowing students to contribute to the translation of laboratory findings into real-world cancer treatments.
Graduates will be well-prepared to pursue careers in oncology research, pharmaceutical development, and healthcare innovation, where they can contribute to the development of cutting-edge cancer therapies and improve patient outcomes. The program’s emphasis on cancer innovation ensures that students are at the forefront of advancements in cancer treatment and personalized medicine.
Key information
Key Facts
Program Title: Master of Research in Cancer Innovation
Degree Type: Master of Research (MRes)
Duration: 1 year
Mode of Study: Full-time, On Campus
Application Deadline: 30th June 2026
Location: Imperial College London, United Kingdom
Field of Study: Medicine
Language of Instruction: English
Program Structure
Semester 1 – Core Cancer Innovation
- Molecular and Cellular Basis of Cancer
- Cancer Biology and Genetics
- Research Methods in Biomedical Science
- Translational Medicine Principles
Semester 2 – Advanced Applications and Research Project
- Innovative Therapeutics and Drug Development
- Cancer Diagnostics and Precision Medicine
- Independent Research Project
- Elective Modules in Immunotherapy, Molecular Oncology, or Biomedical Innovation
Career Opportunities
Graduates from this program are prepared for careers in cancer research, biomedical innovation, and translational medicine. They can work in academic research laboratories, pharmaceutical and biotech companies, healthcare institutions, and clinical research organizations, contributing to the development of novel cancer therapies, diagnostics, and treatment strategies. The program equips students with research, analytical, and experimental skills, enabling them to design and execute studies, analyze complex datasets, and support innovative healthcare solutions. Graduates can also pursue roles in drug development, clinical research, oncology consultancy, or academic research, and they are well-prepared for doctoral studies in cancer biology, molecular medicine, or biomedical sciences.
Why Choose This Program
This program provides a research-focused, one-year pathway into cancer innovation, combining cutting-edge scientific knowledge with practical laboratory and translational research experience. It emphasizes molecular oncology, therapeutic development, and diagnostic innovation, allowing students to gain expertise in developing and evaluating novel cancer treatments. The independent research project provides hands-on experience in experimental design, data analysis, and scientific communication, helping students build a professional portfolio. Graduates leave the program with the skills and knowledge to make an immediate impact in cancer research, biomedical innovation, and healthcare technology, or to pursue advanced doctoral studies in molecular medicine and oncology.
Contact Information
For further information, please contact the admissions office at:
Phone: +44 (0)20 7589 5111
Email: admissions@imperial.ac.uk
Address: Imperial College London, South Kensington Campus, London SW7 2AZ, United Kingdom
